Dr Stock Pick HOT News & Alerts!
_________________________________________
FREE Daily Stock Alerts From DrStockPick.com
_________________________________________
Monday September 28, 2009
DrStockPick.com Stock Report!
XRX, PWRM, ABT, CSRH, CMCSA, CVAT, FMCN
XRX, Xerox Corp.
XRX engages in the development, manufacture, marketing, servicing, and financing of document equipment, software, solutions, and services worldwide.
XRX said Monday it will buy Affiliated Computer Services Inc. for $6.4 billion in cash and stock to create a $22 billion business that combines XRX’s copiers, printers and document management services with the “business process outsourcing” of Dallas-based ACS., joining the expensive race among technology companies to broaden their offerings.
PWRM, Power 3 Medical Products Inc, PWRM.OB
Power3 Medical Products, Inc. is a leading bio-medical company engaged in the commercialization of neurodegenerative disease and cancer biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets. Power3�s patent-pending technologies are being used to develop screening and diagnostic tests for the early detection and prognosis of disease, identify protein biomarkers, and drug targets. Diagnostic tests are targeted toward markets with critical unmet needs in areas including neurodegenerative disease (NuroPro) and breast cancer (BC-SeraPro). Power3 expects to complete phase II clinical validation trials of its blood serum diagnostics for Alzheimer�s disease (NuroPro-AD), and Parkinson�s disease (NuroPro-PD) in 2009 and for breast cancer in 2010, followed by filings with the FDA. Power3 operates a state-of-the-art CLIA certified laboratory in The Woodlands (Houston), Texas. Power3 continues to evolve and enhance its IP portfolio, employing sensitive and specific combinations of biomarkers it has discovered from a broad range of diseases as the basis of highly selective blood-based tests for ALS, Alzheimer�s, and Parkinson�s diseases, and breast cancer.
PWRM Announced that its Chief Scientific Officer is Chair and Keynote Speaker of Session at the BTI Life Sciences 2nd Annual Congress and Expo of Molecular Diagnostics in Beijing, China in November 2009
Further international recognition of validity as the company�s President and CSO, Dr. Ira Goldknopf will deliver an invited Keynote address and chair a session on �Biomarkers and Diagnostics in Personalized Medicine (Track 6-4),� at the BIT Life Sciences 2nd International Congress and Expo of Molecular Diagnostics in Beijing, China, November 19-21, 2009. The Theme of the meeting is �New Leadership of Personalized Medicine.�
More about PWRM at www.power3medical.com
ABT, Abbott Laboratories
ABT manufactures and sells health care products worldwide. ABT’s Pharmaceutical Products segment offers adult and pediatric pharmaceuticals for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, psoriasis, Crohn’s disease, dyslipidemia, HIV infection, hypothyroidism, advanced prostate cancer, endometriosis and central precocious puberty, anemia caused by uterine fibroids, obesity, epilepsy and bipolar disorder, migraines, and secondary hyperparathyroidism; and provides anesthesia products and anti-infectives.
ABT would pay $6.6 billion for the pharmaceutical business of Belgian chemicals maker Solvay in a move to further expand internationally and add to its product portfolio.
CSRH, Consorteum Holdings Inc, CSRH.OB
CSRH is a company in the financial services, payment and transaction processing industries.
CSRH provides electronic transaction processing and management services to financial institutions, healthcare, government, public and private sector companies. CSRH�s services provide customized, innovative technology solutions that create, augment and enhance customers� existing financial, payment and transactional processing systems.
CSRH has established an agreement with a third party partner within the payment processing industry to offer Merchant Discount Rates. Consorteum will leverage this new partnership to offer competitive Merchant Discount Rates and Point of Sale hardware to its new and existing client base.
Quent Rickerby, President & COO of Consorteum Holdings Inc., said, �This agreement will allow Consorteum to offer Canadian clients measurable cost savings on their Credit and Debit Card processing and further enhance the number of products and services we have available.�
Consorteum�s new Merchant Discount Rate program further enhances its list of financial services available to current and future clients. The addition of generating new revenues from debit and credit card transaction processing will ensure long-term revenue growth and incremental residual income. Consorteum will continue to expand its portfolio of financial services, which will further grow the revenues of the company, ensuring increased shareholder value. Processors in North America process in excess of 75 billion electronic payment transactions annually.
More about CSRH at www.consorteum.com
CVAT, Cavitation Technologies Inc, CVAT.OB
CVAT is a �Green-Tech� company, established in 2006 to become a world leader in the development of new cutting edge technologies for the, vegetable oil refining, renewable fuel, petroleum, water treatment, wastewater sanitation, petroleum, food and beverage, chemical industries.
CVAT announced that Biocombustibles y Energias Alternativas (ALS) has entered into a long-term agreement with CTI (Cavitation Technologies Inc) to develop projects in Argentina and throughout Latin America. ALS (www.alsbio.com), partnering with DOW Chemical (www.dow.com), has identified several projects where CTI technology can greatly improve process yields and profitability using CTI and DOW proprietary technology.
According to Roman Gordon, CTI CEO, �We are very pleased to be working with ALS and DOW on these projects and expect that there is a bright future for the combination of our technologies in Argentina as well as the rest of the world where older outdated technologies have been installed.� Mr. Gordon went on further to say, �We are also very excited about the other applications for our technology in the wastewater, petroleum and chemical industries that DOW could have an interest in. We look forward to working with them. These first projects in Argentina represent 480,000 metric tons of fuel per year and more than a $2,500,000 in sales revenue for CTI.�
CVAT More about CVAT at www.cavitationtechnologies.com
CMCSA, Comcast Corporation
CMCSA together with its subsidiaries, provides cable services in the United States. It offers various consumer entertainment, information, and communication products and services to the residential and commercial customers.
MYX�, the nation’s only music entertainment and lifestyle channel that caters to Asian Americans, recently signed an agreement with CMCSA, one of the nation’s leading providers of entertainment, information and communications products and services. Under the agreement, MYX� has been added to Comcast’s Digital Preferred tier on Channel 368 in more than 80 cities in the San Francisco Bay Area this month, including: Novato, Pleasanton, Santa Clara, San Rafael, Sunnyvale, Cupertino, Los Altos, Palo Alto, Saratoga, Milpitas, Mountain View and Vacaville.
FMCN, Focus Media Holding Ltd.
FMCN is China’s leading multi-platform digital media company, operating the largest out-of-home advertising network in China using audiovisual digital displays, based on the number of locations and number of flat-panel television displays in our network, and is also a leading provider of mobile handset advertising and Internet marketing solutions in China.
FMCN announced that the Company and SINA Corporation (Nasdaq: SINA) have jointly reached a decision to not extend the deadline of the agreement announced on December 22, 2008, by which the Company agreed to sell substantially all of the assets of Focus Media’s digital out-of-home advertising networks. The agreement was set to expire if approval from the Chinese Ministry of Commerce was not received by September 30, 2009.
Keep a close eye on XRX, PWRM, ABT, CSRH, CMCSA, CVAT and FMCN, do your homework, and like always BE READY for the ACTION!
No comments:
Post a Comment